Back to library
SARMPreclinical

RAD-160

rad-one-sixty

Research profile · How we handle evidence

Category

SARM

Compound type

Phase / Status

Preclinical

Very early research. Limited data available. Don't touch this stuff yet.

Standard Dose

Unknown - research phase

Unknown

Half-life

Unknown

Plasma elimination

Route(s)

OR

Oral

Research Stage

Preclinical

Animal/in-vitro data only; no human trial evidence.

Overview

RAD-160 is a newer SARM from the same company that made Testolone. It's still in early research with very limited data available. Don't know enough about it yet to recommend it. Think of it as RAD-140's mysterious cousin that nobody really knows.

Plain-language summary

RAD-160 is a newer SARM from the same company that made Testolone. It's still in early research with very limited data available. Don't know enough about it yet to recommend it. Think of it as RAD-140's mysterious cousin that nobody really knows.

Administration Routes

  • Oral

Also known as

RAD160RAD 160Radius SARMRAD-140 successor

Mechanisms

1

Selective Androgen Receptor Modulator (SARM) - binds to androgen receptors in muscle and bone. Probably similar to RAD-140 but we're guessing here.

Detailed mechanism

Selective Androgen Receptor Modulator (SARM) - binds to androgen receptors in muscle and bone. Selectively binds to androgen receptors in muscle and bone tissue while minimizing effects on other organs, promoting anabolic effects with reduced side effects compared to traditional steroids.

Safety

Side effects

  • Unknown - insufficient data
  • Potential testosterone suppression
  • Unknown liver toxicity

Reported benefits

  • Theoretical muscle building
  • Theoretical fat loss
  • May have favorable side effect profile

Safety profile

Limited human safety data. Use with caution and under appropriate supervision. Actually, just don't use it.

Clinical trials

Preclinical studies completed in animal models. Human trials pending. Maybe. Possibly. Who knows?

Structure

Verified structure

RAD-160

No public sequence, formula, or exact registry structure is available for this record.

Structure unavailable

No trustworthy illustration yet

This entry is missing a public exact structure, sequence, or usable formula. The verification record is still stored so it remains visible in the audit trail.

Chemical Formula
Not publicly available
Molecular Weight
Not publicly available
CAS Number
Not publicly available

Stack Context

No stack data available.

References

  1. 1

    RAD140, a selective androgen receptor modulator, reduces aggressive prostate tumor growth - closest-related public SARM research (Cancer Research)

    2017

    View source
  2. 2

    Selective androgen receptor modulators as function promoting therapies (Current Opinion in Clinical Nutrition and Metabolic Care)

    2009

    View source
  3. 3

    Design, synthesis, and preclinical characterization of the selective androgen receptor modulator RAD140 (ACS Medicinal Chemistry Letters)

    2011

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.